Are allogeneic blood transfusions acceptable in elective surgery in colorectal carcinoma?

European Journal of Cancer

Volumn 35, Issue 3, 1999, Pages 352-353

  Marquet, R L ^a   Busch, O R C ^b   Jeekel, J ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CANCER GROWTH; CLINICAL RESEARCH; COLORECTAL CARCINOMA; HUMAN; IMMUNE DEFICIENCY; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0033106285     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00381-5     Document Type: Article

References (7)

1. Opelz G. The role of HLA matching and blood transfusions in the cyclosporine era. Collaborative Transplant Study. Transplant Proc. 21:1989;609-612.
2. Singh S.K., Marquet R.L., de Bruin R.W.F., Hop W.C., Westbroek D.L., Jeekel J. Consequences of blood loss on growth of artificial metastases. Br J Surg. 75:1988;377-379.
3. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation. 55:1993;742-747.
4. Vamvakas E.C. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion. 35:1995;760-768.
5. Busch O.R.C., Hop W.C., Hoynck van Papendrecht M.A., Marquet R.L., Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med. 328:1993;1372-1376.
6. Heiss M.M., Mempel W., Delanoff C., et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol. 9:1994;1859-1867.
7. Houbiers J.G.A., Brand A., van de Watering L.M.G., et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 344:1994;573-578.